COVID-19 Vaccination Timing, Relative to Acute COVID-19, and Subsequent Risk of Long COVID
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
Objectives
Long COVID is a debilitating condition that impacts millions of Americans, but patients and clinicians have little information on how to prevent this disorder. Vaccination is a vital tool in preventing acute COVID-19 and may confer additional protection against Long COVID. There is limited evidence regarding the optimal timing of COVID-19 vaccination (i.e., vaccination schedule) to minimize the risk of Long COVID.
Methods
We applied Longitudinal Targeted Maximum Likelihood Estimation to electronic health record (EHR) data from a retrospective cohort of patients vaccinated against COVID-19 between December 2021 and September 2022. We evaluated the association between binary COVID-19 vaccination status (two or more doses vs. zero doses) and 12-month Long COVID risk among patients diagnosed with acute COVID-19 between December 2021 and September 2022. In addition, we compared the 12-month cumulative risk of Long COVID (ICD-10 code U09.9) among patients diagnosed with acute COVID-19 one to three months after vaccination, three to five months after vaccination, or five to seven months after vaccination while adjusting for relevant high-dimensional baseline and time-dependent covariates.
Results
We analyzed EHR data from a retrospective cohort of 1,558,018 patients. In our binary cohort ( n = 519,980), we found that vaccinated patients had a lower risk of Long COVID than unvaccinated patients (adjusted marginal risk ratio 0.84 (0.81, 0.88)). In our longitudinal cohort ( n = 1,085,291), we did not find a significant difference in Long COVID risk comparing patients who were diagnosed with acute COVID-19 one to three months after vaccination versus patients who were diagnosed with COVID-19 three to five months (adjusted marginal risk ratio 0.93 (95% CI 0.62, 1.41) or 5 to 7 months (adjusted marginal risk ratio 1.06 (95% CI 0.72, 1.56)) after vaccination.
Conclusions
We found that COVID-19 vaccination before SARS-CoV-2 infection was protective against Long COVID, and we did not find that this protection significantly waned within 7 months after vaccination. These findings suggest that COVID-19 vaccination protects against Long COVID.
Article activity feed
-
Strength of evidence
Reviewer(s): L Wynants & R Gottwald (Maastricht University) | 📒📒📒◻️◻️
P Ssentongo (Penn State Health) | 📗📗📗📗◻️ -
Paddy Ssentongo
Review 2: "COVID-19 Vaccination Timing, Relative to Acute COVID-19, and Subsequent Risk of Long COVID"
Reviewers praised the rigorous use of causal inference methods and the application of site-level data quality filters, though one reviewer points out substantial limitations such as outcome misclassification, missing data, and unmeasured confounding due to prior infection status.
-
Laure Wynants, Robin Gottwald
Review 1: "COVID-19 Vaccination Timing, Relative to Acute COVID-19, and Subsequent Risk of Long COVID"
Reviewers praised the rigorous use of causal inference methods and the application of site-level data quality filters, though one reviewer points out substantial limitations such as outcome misclassification, missing data, and unmeasured confounding due to prior infection status.
-
